| pubmed-article:9743230 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9743230 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:9743230 | lifeskim:mentions | umls-concept:C0025936 | lld:lifeskim |
| pubmed-article:9743230 | lifeskim:mentions | umls-concept:C2246761 | lld:lifeskim |
| pubmed-article:9743230 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:9743230 | lifeskim:mentions | umls-concept:C1677784 | lld:lifeskim |
| pubmed-article:9743230 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:9743230 | pubmed:dateCreated | 1998-10-1 | lld:pubmed |
| pubmed-article:9743230 | pubmed:abstractText | The first step in reverse cholesterol transport is the movement of cholesterol out of cells onto lipoprotein acceptors in the interstitial fluid. The contribution of specific lipoprotein components to this process remains to be established. In this study, the role of human apolipoproteins (apo) A-I and A-II in the efflux of cellular cholesterol was investigated in transgenic mouse models in which the expression of murine apoA-I was abolished due to gene targeting (A-IKO). Serum from A-IKO mice and from mice expressing human apoA-I and/or human apoA-II was incubated with [3H]cholesterol-labeled Fu5AH rat hepatoma cells for 4 hours at 37 degrees C. The cholesterol efflux to the serum of A-IKO mice was markedly lower than that to the serum of mice transgenic for human apoA-I (5.0 +/- 1.5% versus 25.0 +/- 4.0%). Expression of human apoA-II alone did not modify the cholesterol efflux capacity of A-IKO mouse serum. Cholesterol efflux to serum of mice expressing human apoA-II together with human apoA-I was significantly lower than that to human apoA-I mouse serum (20.0 +/- 2.3% versus 25.0 +/- 4.0%). Regression analysis of cholesterol efflux versus the lipid/apolipoprotein concentrations of mouse serum suggested that 3 independent factors contribute to determine the cholesterol efflux potential of serum: the apolipoprotein composition of HDL, the serum concentration of HDL phospholipids, and the presence of a small fraction of particles containing apoA-I. | lld:pubmed |
| pubmed-article:9743230 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9743230 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9743230 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9743230 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:9743230 | pubmed:issn | 1079-5642 | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:SirtoriC RCR | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:ParoliniCC | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:FumagalliRR | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:BerniniFF | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:ChiesaGG | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:FranceschiniG... | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:ColomboNN | lld:pubmed |
| pubmed-article:9743230 | pubmed:author | pubmed-author:CanavesiMM | lld:pubmed |
| pubmed-article:9743230 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9743230 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:9743230 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9743230 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9743230 | pubmed:pagination | 1417-23 | lld:pubmed |
| pubmed-article:9743230 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:meshHeading | pubmed-meshheading:9743230-... | lld:pubmed |
| pubmed-article:9743230 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9743230 | pubmed:articleTitle | Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice. | lld:pubmed |
| pubmed-article:9743230 | pubmed:affiliation | Center E. Grossi Paoletti and Institute of Pharmacological Sciences, University of Milano, Italy. | lld:pubmed |
| pubmed-article:9743230 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9743230 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:11806 | entrezgene:pubmed | pubmed-article:9743230 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9743230 | lld:pubmed |
